These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33282950)

  • 1. A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer.
    Luo D; Shan Z; Liu Q; Cai S; Li Q; Li X
    Biomed Res Int; 2020; 2020():4845360. PubMed ID: 33282950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a novel epigenetic signature for predicting prognosis in colon cancer.
    Luo D; Liu Q; Shan Z; Cai S; Li Q; Li X
    J Cell Physiol; 2020 Nov; 235(11):8714-8723. PubMed ID: 32329069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
    Wang Y; Zhang L; Wang B; Cheng Y
    Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
    Fan Q; Liu B
    Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 65‑gene signature for prognostic prediction in colon adenocarcinoma.
    Jiang H; Du J; Gu J; Jin L; Pu Y; Fei B
    Int J Mol Med; 2018 Apr; 41(4):2021-2027. PubMed ID: 29393333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose metabolism-based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma.
    Bai Z; Yan C; Nie Y; Zeng Q; Xu L; Wang S; Chang D
    J Gene Med; 2024 Jan; 26(1):e3620. PubMed ID: 37973153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a metabolic risk model predicting prognosis of colon cancer.
    Zuo D; Li C; Liu T; Yue M; Zhang J; Ning G
    Sci Rep; 2021 Mar; 11(1):6837. PubMed ID: 33767290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer.
    Ren J; Feng J; Song W; Wang C; Ge Y; Fu T
    Clin Exp Med; 2020 Nov; 20(4):535-544. PubMed ID: 32772211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel gene signatures for prognosis prediction in ovarian cancer.
    Bao M; Zhang L; Hu Y
    J Cell Mol Med; 2020 Sep; 24(17):9972-9984. PubMed ID: 32666642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nine-gene signature to improve prognosis prediction of colon carcinoma.
    Zhao J; Wang Y; Gao J; Wang Y; Zhong X; Wu X; Li H
    Cell Cycle; 2021 May; 20(10):1021-1032. PubMed ID: 33985413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of Gene Expression Profiles Identifies a
    Chen Z; Chen M; Xue Z; Zhu X
    Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and validation of the prognostic signature of a novel demethylation-related gene associated with the clinical features of colon cancer.
    Kang K; Huang H; Chen Z
    Int Immunopharmacol; 2024 Sep; 139():112798. PubMed ID: 39079198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor expression as a predictor of colon cancer prognosis: a machine learning practice.
    Liu J; Dong C; Jiang G; Lu X; Liu Y; Wu H
    BMC Med Genomics; 2020 Sep; 13(Suppl 9):135. PubMed ID: 32957968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
    Liang L; Zeng JH; Qin XG; Chen JQ; Luo DZ; Chen G
    Cell Physiol Biochem; 2018; 48(2):475-490. PubMed ID: 30016783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a Signature Composed of 14 Immune Genes to Judge the Prognosis and Immune Infiltration of Colon Cancer.
    Mo S; Pei Z; Dai L
    Genet Test Mol Biomarkers; 2021 Mar; 25(3):163-178. PubMed ID: 33734891
    [No Abstract]   [Full Text] [Related]  

  • 17. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
    Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
    J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent prognostic genes and mechanism investigation for colon cancer.
    Li C; Shen Z; Zhou Y; Yu W
    Biol Res; 2018 Apr; 51(1):10. PubMed ID: 29653552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.